DRTSAlpha Tau Medical Ltd.

$14.43+253% 1Y

What is the market doing?

Mixed

No clear lean: nothing decisive, though in an uptrend.

1 good, 2 neutral
TrendUptrendderived · Oct 9, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +51% vs its 200-day average.

Insider conviction−$291K (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026

Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).

Short interest4.3% of sharesFINRA · Sep 15, 2026

Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How DRTS is trading

Alpha Tau Medical Ltd. is +253% over the past year while the S&P 500 is +18%: 235 points ahead of the market.

+253%

1-year return · S&P 500 +18%

vs 200-day average
+51%

vs 200-day average · a clear uptrend

RSI (14)
38

RSI (14) · neutral

Below its 52-week high
7.0%

Below its 52-week high

Sep 18, 2024$2.17 – $15.51 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$14.43
1 monthS&P 500 +2.7%
−0.03%
1 yearS&P 500 +18%
+253%
5 yearsS&P 500 +88%
+47%
vs 50-day average$14.32
+0.78%
52-week high
$15.51
52-week low
$3.47
Annualised volatility
66%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
−$352K
Calendar-year price return
YearReturn
2026 (year to date)+192%
2025+60%
2024+3.0%
2023−5.3%
2022−68%
Average return by calendar month, 2021–2026
MonthYearsPositiveAverage
Jan55 of 5+19%
Feb52 of 5−5.5%
Mar51 of 5−5.7%
Apr64 of 6−2.6%
May64 of 6+11%
Jun66 of 6+5.8%
Jul63 of 6+0.50%
Aug64 of 6−0.29%
Sep64 of 6+4.4%
Oct61 of 6−7.5%
Nov51 of 5+0.22%
Dec52 of 5+1.2%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.